Nightingale Health Oyj is a health technology company based in Helsinki, Finland, founded in 2002. The company specializes in advanced health checks that identify disease risks from a single blood sample, with a particular focus on chronic diseases. Its services include blood analysis, self-collection kits, urine analysis, and biomarker services, which are utilized by various research programs, universities, and healthcare providers. Nightingale Health was listed on the Nasdaq Helsinki in March 2025 under the ticker symbol HEALTH. As of August 2026, the company employs approximately 103 individuals. Nightingale Health has formed collaborations with notable organizations, including the UK Biobank, Kaiser Foundation, ZOE, Boston Heart Diagnostics, 23andMe, and Phenome Health.
AI-researched from public web sources, not from the exchange listing itself — may contain errors or omissions and is not a substitute for verifying independently.
Nightingale Health Oyj's offering is currently approved on OTHER. Nightingale Health Oyj is headquartered in Finland. It is classified under Biotech.
Other IPOs DiscoverIPO tracks that share a sector, market, or underwriter with Nightingale Health Oyj.
Drop a live deal card into your own site — works in WordPress, Ghost, Notion, Webflow, and any self-hosted page that allows an <iframe>. It does not work in Substack or in an emailed newsletter — no email client, and Substack itself, supports arbitrary iframes. For those, use the share image or the attribution text below instead.
<iframe src="https://www.discoveripo.com/embed/nightingale-health-oyj" width="100%" height="300" style="border:0;max-width:560px" loading="lazy" title="Nightingale Health Oyj — DiscoverIPO"></iframe>
Dark by default. For a light background, use https://www.discoveripo.com/embed/nightingale-health-oyj?theme=light as the src instead.
https://www.discoveripo.com/ipo/nightingale-health-oyj/opengraph-image
Nightingale Health Oyj IPO details — tracked by DiscoverIPO: https://www.discoveripo.com/ipo/nightingale-health-oyj?utm_source=embed&utm_medium=text&utm_campaign=nightingale-health-oyj
Get emailed when Nightingale Health Oyj's terms, price, or expected date change — no weekly noise, just this company.
Nightingale Health Oyj is listing on OTHER.
Nightingale Health Oyj is a health technology company based in Helsinki, Finland, founded in 2002. The company specializes in advanced health checks that identify disease risks from a single blood sample, with a particular focus on chronic diseases. Its services include blood analysis, self-collection kits, urine analysis, and biomarker services, which are utilized by various research programs, universities, and healthcare providers. Nightingale Health was listed on the Nasdaq Helsinki in March 2025 under the ticker symbol HEALTH. As of August 2026, the company employs approximately 103 individuals. Nightingale Health has formed collaborations with notable organizations, including the UK Biobank, Kaiser Foundation, ZOE, Boston Heart Diagnostics, 23andMe, and Phenome Health.
European Securities and Markets Authority's Prospectus Regulation register — a prospectus approval date, not a confirmed listing date. Retrieved Aug 26, 2026.
View the original filing on ESMA →Not investment advice. DiscoverIPO is an informational database. Nothing here is a recommendation to buy or sell any security, and no content should be relied on as financial advice. All figures come from public filings and exchange calendars, may be incomplete or out of date, and should be verified against the original source before you act on them.
We use analytics and marketing cookies to understand traffic and improve the site. Cookie Policy